Cite
HARVARD Citation
Mackenzie, I. et al. (2020). Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial. Lancet. 396 (10264), pp. 1745-1757. [Online].